ExtremitiesTop Stories

Stryker boosts bone implants with $4 billion Wright Medical buyout

Saumya Joseph / Nov. 4, 2019

(Reuters) – Medical device maker Stryker Corp (SYK.N) said on Monday it would buy smaller rival Wright Medical Group (WMGI.O) for about $4 billion in cash, to gain access to the fast-growing upper-body joint implants business.

Wright Medical, which recorded sales of $836 million last year, is among the top makers of implants to treat upper-body joint injuries such as in shoulder or wrist, as well as lower body including in foot and ankle.

Wells Fargo analyst Larry Biegelsen said the deal would give Stryker a leading position in the shoulder market, which has been a major gap in the device maker’s orthopedic portfolio.

“Stryker will meaningfully bolster its ability to compete and innovate in the nearly $2 billion global shoulder market,” Chief Executive Officer Kevin Lobo said in a conference call with analysts.

Stryker, however, may have to make some divestments in its ankle implant portfolio to avoid antitrust issues as Wright Medical has a near 70% share of the total ankle replacement market, analyst Biegelsen said.

READ THE REST HERE

Drue De Angelis

Drue is Managing Partner for The De Angelis Group, Executive Search firm exclusively for the Ortho & Spine industry.

Related Articles

Back to top button